Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18045
Title: Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.
Authors: Mitsios, John P;Ekinci, Elif I;Mitsios, Gregory P;Churilov, Leonid;Thijs, Vincent N
Affiliation: The University of Melbourne, Parkville, Melbourne, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
The Florey Institute of Neuroscience & Mental Health, Melbourne, Victoria, Australia
Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Neurology, Austin Health, Heidelberg, Victoria, Australia
Stroke Division, The Florey Institute of Neuroscience & Mental Health University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: 17-May-2018
EDate: 2018
Citation: Journal of the American Heart Association 2018; 7(11): e007858
Abstract: Diabetes mellitus is a major risk factor for ischemic stroke. Rising hemoglobin A1c (HbA1c) levels are associated with microvascular diabetes mellitus complication development; however, this relationship has not been established for stroke risk, a macrovascular complication. We conducted a systematic review and meta-analysis of observational cohort and nested case-control cohort studies assessing the association between rising HbA1c levels and stroke risk in adults (≥18 years old) with and without type 1 or type 2 diabetes mellitus. Random-effects model meta-analyses were used to calculate pooled adjusted hazard ratios (HRs) and their precision. The systematic review yielded 36 articles, of which 29 articles (comprising n=532 779 participants) were included in our meta-analysis. Compared to non-diabetes mellitus range HbA1c (<5.7%), diabetes mellitus range HbA1c (≥6.5%) was associated with an increased risk of first-ever stroke with average HR (95% confidence interval) of 2.15 (1.76, 2.63), whereas pre-diabetes mellitus range HbA1c (5.7-6.5%) was not (average HR [95% confidence interval], 1.19 [0.87, 1.62]). For every 1% HbA1c increment (or equivalent), the average HR (95% confidence interval) for first-ever stroke was 1.12 (0.91, 1.39) in non-diabetes mellitus cohorts and 1.17 (1.09, 1.25) in diabetes mellitus cohorts. For every 1% HbA1c increment, both non-diabetes mellitus and diabetes mellitus cohorts had a higher associated risk of first-ever ischemic stroke with average HR (95% confidence interval) of 1.49 (1.32, 1.69) and 1.24 (1.11, 1.39), respectively. A rising HbA1c level is associated with increased first-ever stroke risk in cohorts with a diabetes mellitus diagnosis and increased risk of first-ever ischemic stroke in non-diabetes mellitus cohorts. These findings suggest that more intensive HbA1c glycemic control targets may be required for optimal ischemic stroke prevention.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18045
DOI: 10.1161/JAHA.117.007858
ORCID: 0000-0003-2372-395X
0000-0002-9807-6606
0000-0002-6614-8417
PubMed URL: 29773578
Type: Journal Article
Review
Subjects: cerebrovascular disease/stroke
diabetes mellitus
hemoglobin A1c
meta‐analysis
risk
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.